Primate lentiviruses modulate NF-HIV, SIV, NF-κB, Nef, Vpu, Tat, LTRB activity by multiple mechanisms to fine-tune viral and cellular gene expression

Frontiers in Microbiology

Volumn 8, Issue FEB, 2017, Pages

  Heusinger, Elena ^a   Kirchhoff, Frank ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

HIV; LTR; Nef; NF B; SIV; Tat; Vpu

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEF PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSACTIVATOR PROTEIN; VIRAL PROTEIN;

ANTIVIRAL ACTIVITY; CD4+ T LYMPHOCYTE; CELL SURVIVAL; DNA BINDING; DNA DAMAGE RESPONSE; GENE EXPRESSION; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE EVASION; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; LENTIVIRINAE; LONG TERMINAL REPEAT; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; T CELL DEPLETION; UBIQUITINATION; VIRUS EXPRESSION; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

EID: 85014424945     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2017.00198     Document Type: Review

References (108)

1. Akari, H., Bour, S., Kao, S., Adachi, A., and Strebel, K. (2001). The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor κB-dependent expression of antiapoptotic factors. J. Exp. Med. 194, 1299-1311. doi: 10.1084/jem.194.9.1299.
2. Alexander, L., Du, Z., Rosenzweig, M., Jung, J. U., and Desrosiers, R. C. (1997). A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation. J. Virol. 71, 6094-6099.
3. Arhel, N., Lehmann, M., Clauss, K., Nienhaus, G. U., Piguet, V., and Kirchhoff, F. (2009). The inability to disrupt the immunological synapse between infected human T cells and APCs distinguishes HIV-1 from most other primate lentiviruses. J. Clin. Invest. 119, 2965-2975. doi: 10.1172/JCI38994.
4. Arhel, N. J., Souquere-Besse, S., Munier, S., Souque, P., Guadagnini, S., Rutherford, S., et al. (2007). HIV-1 DNA flap formation promotes uncoating of the pre-integration complex at the nuclear pore. EMBO J. 26, 3025-3037. doi: 10.1038/sj.emboj.7601740.
5. Bachu, M., Yalla, S., Asokan, M., Verma, A., Neogi, U., Sharma, S., et al. (2012). Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance. J. Biol. Chem. 287, 44714-44735. doi: 10.1074/jbc.M112.397158.
6. Bailes, E., Gao, F., Bibollet-Ruche, F., Courgnaud, V., Peeters, M., Marx, P. A., et al. (2003). Hybrid origin of SIV in Chimpanzees. Science 300, 1713-1713. doi: 10.1126/science.1080657.
7. Bandres, J. C., and Ratner, L. (1994). Human immunodeficiency virus type 1 Nef protein down-regulates transcription factors NF-kappa B and AP-1 in human T cells in vitro after T-cell receptor stimulation. J. Virol. 68, 3243-3249.
8. Barboric, M., Nissen, R. M., Kanazawa, S., Jabrane-Ferrat, N., and Peterlin, B. M. (2001). NF-κB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol. Cell 8, 327-337. doi: 10.1016/S1097-2765(01)00314-8.
9. Baur, A. S., Sass, G., Laffert, B., Willbold, D., Cheng-Mayer, C., and Peterlin, B. M. (1997). The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. Immunity 6, 283-291. doi: 10.1016/S1074-7613(00)80331-3.
10. Baur, A. S., Sawai, E. T., Dazin, P., Fantl, W. J., Cheng-Mayer, C., and Matija Peterlin, B. (1994). HIV-1 nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1, 373-384. doi: 10.1016/1074-7613(94)90068-X.
11. Bell, I., Ashman, C., Maughan, J., Hooker, E., Cook, F., and Reinhart, T. A. (1998). Association of simian immunodeficiency virus Nef with the T-cell receptor (TCR) ζ chain leads to TCR down-modulation. J. Gen. Virol. 79, 2717-2727. doi: 10.1099/0022-1317-79-11-2717.
12. Bell, I., Schaefer, T. M., Trible, R. P., Amedee, A., and Reinhart, T. A. (2001). Down-modulation of the costimulatory molecule, CD28, is a conserved activity of multiple SIV Nefs and is dependent on histidine 196 of Nef. Virology 283, 148-158. doi: 10.1006/viro.2001.0872.
13. Blanco-Melo, D., Venkatesh, S., and Bieniasz, P. D. (2016). Origins and evolution of tetherin, an orphan antiviral gene. Cell Host Microbe 20, 189-201. doi: 10.1016/j.chom.2016.06.007.
14. Boomer, J. S., and Green, J. M. (2010). An enigmatic tail of CD28 signaling. Cold Spring Harb. Perspect. Biol. 2:a002436. doi: 10.1101/cshperspect.a002436.
15. Bour, S., Perrin, C., Akari, H., and Strebel, K. (2001). The human immunodeficiency virus type 1 Vpu protein inhibits NF-κB activation by interfering with βTrCP-mediated degradation of IκB. J. Biol. Chem. 276, 15920-15928. doi: 10.1074/jbc.M010533200.
16. Cary, D. C., Fujinaga, K., and Peterlin, B. M. (2016). Molecular mechanisms of HIV latency. J. Clin. Invest. 126, 448-454. doi: 10.1172/JCI80565.
17. Chahroudi, A., Bosinger, S. E., Vanderford, T. H., Paiardini, M., and Silvestri, G. (2012). Natural SIV hosts: showing AIDS the door. Science 335, 1188-1193. doi: 10.1126/science.1217550.
18. Chan, J. K., and Greene, W. C. (2012). Dynamic roles for NF-κB in HTLV-I and HIV-1 retroviral pathogenesis. Immunol. Rev. 246, 286-310. doi: 10.1111/j.1600-065X.2012.01094.x.
19. Cheng, J., Montecalvo, A., and Kane, L. P. (2011). Regulation of NF-κB induction by TCR/CD28. Immunol. Res. 50, 113-117. doi: 10.1007/s12026-011-8216-z.
20. Cildir, G., Low, K. C., and Tergaonkar, V. (2016). Noncanonical NF-κB signaling in health and disease. Trends Mol. Med. 22, 414-429. doi: 10.1016/j.molmed.2016.03.002.
21. Cocka, L. J., and Bates, P. (2012). Identification of alternatively translated Tetherin isoforms with differing antiviral and signaling activities. PLoS Pathog. 8:e1002931. doi: 10.1371/journal.ppat.1002931.
22. Colomer-Lluch, M., Gollahon, L. S., and Serra-Moreno, R. (2016). Anti-HIV factors: targeting each step of HIV's replication cycle. Curr. HIV Res. 14, 175-182. doi: 10.2174/1570162X14999160224094621.
23. Coudronniere, N., Villalba, M., Englund, N., and Altman, A. (2000). NF-κB activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-θ. Proc. Natl. Acad. Sci. U.S.A. 97, 3394-3399. doi: 10.1073/pnas.97.7.3394.
24. Dharan, A., Talley, S., Tripathi, A., Mamede, J. I., Majetschak, M., Hope, T. J., et al. (2016). KIF5B and Nup358 cooperatively mediate the nuclear import of HIV-1 during infection. PLOS Pathog. 12:e1005700. doi: 10.1371/journal.ppat.1005700.
25. Doyle, T., Goujon, C., and Malim, M. H. (2015). HIV-1 and interferons: who's interfering with whom? Nat. Rev. Microbiol. 13, 403-413. doi: 10.1038/nrmicro3449.
26. Fenard, D., Yonemoto, W., de Noronha, C., Cavrois, M., Williams, S. A., and Greene, W. C. (2005). Nef is physically recruited into the immunological synapse and potentiates T cell activation early after TCR engagement. J. Immunol. 175, 6050-6057. doi: 10.4049/JIMMUNOL.175.9.6050.
27. Fiume, G., Vecchio, E., De Laurentiis, A., Trimboli, F., Palmieri, C., Pisano, A., et al. (2012). Human immunodeficiency virus-1 Tat activates NF-κB via physical interaction with IκB-a and p65. Nucleic Acids Res. 40, 3548-3562. doi: 10.1093/nar/gkr1224.
28. Fortin, J.-F., Barat, C., Beauséjour, Y., Barbeau, B., and Tremblay, M. J. (2004). Hyper-responsiveness to stimulation of human immunodeficiency virus-infected CD4+ T cells requires Nef and Tat virus gene products and results from higher NFAT, NF-κB, and AP-1 induction. J. Biol. Chem. 279, 39520-39531. doi: 10.1074/jbc.M407477200.
29. Galão, R. P., Le Tortorec, A., Pickering, S., Kueck, T., and Neil, S. J. D. (2012). Innate sensing of HIV-1 assembly by Tetherin induces NFκB-dependent proinflammatory responses. Cell Host Microbe 12, 633-644. doi: 10.1016/j.chom.2012.10.007.
30. Galão, R. P., Pickering, S., Curnock, R., and Neil, S. J. D. (2014). Retroviral retention activates a syk-dependent HemITAM in human tetherin. Cell Host Microbe 16, 291-303. doi: 10.1016/j.chom.2014.08.005.
31. Ghosh, S., and Hayden, M. S. (2012). Celebrating 25 years of NF-κB research. Immunol. Rev. 246, 5-13. doi: 10.1111/j.1600-065X.2012.01111.x.
32. Hayden, M. S., West, A. P., and Ghosh, S. (2006). SnapShot: NF-κB signaling pathways. Cell 127, 1286-1287. doi: 10.1016/j.cell.2006.12.005.
33. Heigele, A., Kmiec, D., Regensburger, K., Langer, S., Peiffer, L., Stürzel, C. M., et al. (2016). The potency of nef-mediated SERINC5 antagonism correlates with the prevalence of primate lentiviruses in the wild. Cell Host Microbe 20, 381-391. doi: 10.1016/j.chom.2016.08.004.
34. Herbein, G., Varin, A., Larbi, A., Fortin, C., Mahlknecht, U., Fulop, T., et al. (2008). Nef and TNFa are coplayers that favor HIV-1 replication in monocytic cells and primary macrophages. Curr. HIV Res. 6, 117-129. doi: 10.2174/157016208783884985.
35. Heusinger, E., Kluge, S. F., Kirchhoff, F., and Sauter, D. (2015). Early vertebrate evolution of the host restriction factor tetherin. J. Virol. 89, 12154-12165. doi: 10.1128/JVI.02149-15.
36. Hiscott, J., Kwon, H., Génin, P., Ghosh, S., May, M., Kopp, E., et al. (2001). Hostile takeovers: viral appropriation of the NF-κB pathway. J. Clin. Invest. 107, 143-151. doi: 10.1172/JCI11918.
37. Hotter, D., Sauter, D., and Kirchhoff, F. (2013). Emerging role of the host restriction factor tetherin in viral immune sensing. J. Mol. Biol. 425, 4956-4964. doi: 10.1016/j.jmb.2013.09.029.
38. Iafrate, A. J., Bronson, S., and Skowronski, J. (1997). Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J. 16, 673-684. doi: 10.1093/emboj/16.4.673.
39. Jakobsen, M. R., Olagnier, D., and Hiscott, J. (2015). Innate immune sensing of HIV-1 infection. Curr. Opin. HIV AIDS 10, 96-102. doi: 10.1097/COH.0000000000000129.
40. Janardhan, A., Swigut, T., Hill, B., Myers, M. P., and Skowronski, J. (2004). HIV-1 Nef binds the DOCK2-ELMO1 complex to activate rac and inhibit lymphocyte chemotaxis. PLoS Biol. 2:E6. doi: 10.1371/journal.pbio.0020006.
41. Jia, B., Serra-Moreno, R., Neidermyer, W., Rahmberg, A., Mackey, J., Fofana, I. B., et al. (2009). Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by Tetherin/BST2. PLoS Pathog. 5:e1000429. doi: 10.1371/journal.ppat.1000429.
42. Jiang, G., and Dandekar, S. (2015). Targeting NF-κB signaling with protein kinase C agonists as an emerging strategy for combating HIV latency. AIDS Res. Hum. Retroviruses 31, 4-12. doi: 10.1089/AID.2014.0199.
43. Karin, M., and Ben-Neriah, Y. (2000). Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18, 621-663. doi: 10.1146/annurev.immunol.18.1.621.
44. Keele, B. F., Jones, J. H., Terio, K. A., Estes, J. D., Rudicell, R. S., Wilson, M. L., et al. (2009). Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz. Nature 460, 515-519. doi: 10.1038/nature08200.
45. Khalid, M., Yu, H., Sauter, D., Usmani, S. M., Schmokel, J., Feldman, J., et al. (2012). Efficient Nef-mediated downmodulation of TCR-CD3 and CD28 is associated with high CD4+ T cell counts in viremic HIV-2 infection. J. Virol. 86, 4906-4920. doi: 10.1128/JVI.06856-11.
46. Kinoshita, S., Chen, B. K., Kaneshima, H., and Nolan, G. P. (1998). Host control of HIV-1 parasitism in T Cells by the nuclear factor of activated T cells. Cell 95, 595-604. doi: 10.1016/S0092-8674(00)81630-X.
47. Kirchhoff, F. (2009). Is the high virulence of HIV-1 an unfortunate coincidence of primate lentiviral evolution? Nat. Rev. Microbiol. 7:467. doi: 10.1038/nrmicro2111.
48. Kirchhoff, F. (2010). Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 8, 55-67. doi: 10.1016/j.chom.2010.06.004.
49. Kluge, S. F., Sauter, D., and Kirchhoff, F. (2015). SnapShot: antiviral restriction factors. Cell 163, 774-774.e1. doi: 10.1016/j.cell.2015.10.019.
50. Kogan, M., Deshmane, S., Sawaya, B. E., Gracely, E. J., Khalili, K., and Rappaport, J. (2013). Inhibition of NF-κB activity by HIV-1 Vpr is dependent on Vpr binding protein. J. Cell. Physiol. 228, 781-790. doi: 10.1002/jcp.24226.
51. Kumar, A., Abbas, W., Colin, L., Khan, K. A., Bouchat, S., Varin, A., et al. (2016). Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line. Sci. Rep. 6:24090. doi: 10.1038/srep24090.
52. Le Tortorec, A., and Neil, S. J. D. (2009). Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein. J. Virol. 83, 11966-11978. doi: 10.1128/JVI.01515-09.
53. Lelek, M., Di Nunzio, F., Henriques, R., Charneau, P., Arhel, N., and Zimmer, C. (2012). Superresolution imaging of HIV in infected cells with FlAsH-PALM. Proc. Natl. Acad. Sci. U.S.A. 109, 8564-8569. doi: 10.1073/pnas.1013267109.
54. Liang, Z., Liu, R., Lin, Y., Liang, C., Tan, J., and Qiao, W. (2015). HIV-1 Vpr protein activates the NF-κB pathway to promote G2/M cell cycle arrest. Virol. Sin. 30, 441-448. doi: 10.1007/s12250-015-3654-8.
55. Liu, R., Lin, Y., Jia, R., Geng, Y., Liang, C., Tan, J., et al. (2014). HIV-1 Vpr stimulates NF-κB and AP-1 signaling by activating TAK1. Retrovirology 11:45. doi: 10.1186/1742-4690-11-45.
56. Liu, R., Tan, J., Lin, Y., Jia, R., Yang, W., Liang, C., et al. (2013). HIV-1 Vpr activates both canonical and noncanonical NF-κB pathway by enhancing the phosphorylation of IKKα/β. Virology 439, 47-56. doi: 10.1016/j.virol.2013.01.020.
57. Mangino, G., Percario, Z. A., Fiorucci, G., Vaccari, G., Acconcia, F., Chiarabelli, C., et al. (2011). HIV-1 Nef induces proinflammatory state in macrophages through its acidic cluster domain: involvement of TNF alpha receptor associated factor 2. PLoS ONE 6:e22982. doi: 10.1371/journal.pone.0022982.
58. McCool, K. W., and Miyamoto, S. (2012). DNA damage-dependent NF-κB activation: NEMO turns nuclear signaling inside out. Immunol. Rev. 246, 311-326. doi: 10.1111/j.1600-065X.2012.01101.x.
59. Miyamoto, S. (2011). Nuclear initiated NF-κB signaling: NEMO and ATM take center stage. Cell Res. 21, 116-130. doi: 10.1038/cr.2010.179.
60. Müller, M. R., and Rao, A. (2010). NFAT, immunity and cancer: a transcription factor comes of age. Nat. Rev. Immunol. 10, 645-656. doi: 10.1038/nri2818.
61. Nabel, G., and Baltimore, D. (1987). An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 329, 219-222.
62. Nabel, G. J., and Verma, I. M. (1993). Proposed NF-κB/IκB family nomenclature. Genes Dev. 7, 2063. doi: 10.1101/gad.7.11.2063.
63. Napetschnig, J., and Wu, H. (2013). Molecular basis of NF-κB signaling. Annu. Rev. Biophys. 42, 443-468. doi: 10.1146/annurev-biophys-083012-130338.
64. Nelson, D. E., Ihekwaba, A. E. C., Elliott, M., Johnson, J. R., Kell, D. B., and White, M. R. H. (2004). Oscillations in NF-κB signaling control the dynamics of gene expression. Science 306, 704-709. doi: 10.1126/science.1099962.
65. Niederman, T. M., Garcia, J. V., Hastings, W. R., Luria, S., and Ratner, L. (1992). Human immunodeficiency virus type 1 Nef protein inhibits NF-κB induction in human T cells. J. Virol. 66, 6213-6219.
66. Nyamweya, S., Hegedus, A., Jaye, A., Rowland-Jones, S., Flanagan, K. L., and Macallan, D. C. (2013). Comparing HIV-1 and HIV-2 infection: lessons for viral immunopathogenesis. Rev. Med. Virol. 23, 221-240. doi: 10.1002/rmv.1739.
67. Oeckinghaus, A., and Ghosh, S. (2009). The NF-κB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol. 1:a000034. doi: 10.1101/cshperspect.a000034.
68. Panday, A., Inda, M. E., Bagam, P., Sahoo, M. K., Osorio, D., and Batra, S. (2016). Transcription factor NF-κB: an update on intervention strategies. Arch. Immunol. Ther. Exp. (Warsz) 64, 463-483. doi: 10.1007/s00005-016-0405-y.
69. Paul, S., and Schaefer, B. C. (2013). A new look at T cell receptor signaling to nuclear factor-κB. Trends Immunol. 34, 269-281. doi: 10.1016/j.it.2013.02.002.
70. Pertel, T., Hausmann, S., Morger, D., Züger, S., Guerra, J., Lascano, J., et al. (2011). TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472, 361-365. doi: 10.1038/nature09976.
71. Pfeffer, L. M. (2011). The role of nuclear factor κB in the interferon response. J. Interf. cytokine Res. 31, 553-559. doi: 10.1089/jir.2011.0028.
72. Postler, T. S., and Desrosiers, R. C. (2012). The cytoplasmic domain of the HIV-1 glycoprotein gp41 induces NF-κB activation through TGF-β-activated kinase 1. Cell Host Microbe 11, 181-193. doi: 10.1016/j.chom.2011.12.005.
73. Rasaiyaah, J., Tan, C. P., Fletcher, A. J., Price, A. J., Blondeau, C., Hilditch, L., et al. (2013). HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 503, 402-405. doi: 10.1038/nature12769.
74. Roux, P., Alfieri, C., Hrimech, M., Cohen, E. A., and Tanner, J. E. (2000). Activation of transcription factors NF-κB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression. J. Virol. 74, 4658-4665. doi: 10.1128/JVI.74.10.4658-4665.2000.
75. Sandberg, J. K., Andersson, S. K., Bächle, S. M., Nixon, D. F., and Moll, M. (2012). HIV-1 Vpu interference with innate cell-mediated immune mechanisms. Curr. HIV Res. 10, 327-333. doi: 10.2174/157016212800792513.
76. Sauter, D., Hotter, D., Van Driessche, B., Stürzel, C. M., Kluge, S. F., Wildum, S., et al. (2015). Differential regulation of NF-κB-mediated proviral and antiviral host gene expression by primate lentiviral nef and vpu proteins. Cell Rep. 10, 586-600. doi: 10.1016/j.celrep.2014.12.047.
77. Sauter, D., and Kirchhoff, F. (2016). IFITMs: important factors in trans-mission of HIV-1. Cell Host Microbe 20, 407-408. doi: 10.1016/j.chom.2016.09.009.
78. Sauter, D., Schindler, M., Specht, A., Landford, W. N., Münch, J., Kim, K.-A., et al. (2009). Tetherin-Driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 6, 409-421. doi: 10.1016/j.chom.2009.10.004.
79. Sawai, E. T., Baur, A., Struble, H., Peterlin, B. M., Levy, J. A., and Cheng-Mayer, C. (1994). Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 91, 1539-1543. doi: 10.1073/pnas.91.4.1539.
80. Schindler, M., Münch, J., Kutsch, O., Li, H., Santiago, M. L., Bibollet-Ruche, F., et al. (2006). Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125, 1055-1067. doi: 10.1016/j.cell.2006.04.033.
81. Schindler, M., Schmökel, J., Specht, A., Li, H., Münch, J., Khalid, M., et al. (2008). Inefficient Nef-mediated downmodulation of CD3 and MHC-I correlates with loss of CD4+T cells in natural SIV infection. PLoS Pathog. 4:e1000107. doi: 10.1371/journal.ppat.1000107.
82. Schmökel, J., Sauter, D., Schindler, M., Leendertz, F. H., Bailes, E., Dazza, M.-C., et al. (2011). The presence of a vpu gene and the lack of Nef-mediated downmodulation of T cell receptor-CD3 are not always linked in primate lentiviruses. J. Virol. 85, 742-752. doi: 10.1128/JVI.02087-10.
83. Schrager, J. A., Der Minassian, V., and Marsh, J. W. (2002). HIV Nef increases T cell ERK MAP kinase activity. J. Biol. Chem. 277, 6137-6142. doi: 10.1074/jbc.M107322200.
84. Schrager, J. A., and Marsh, J. W. (1999). HIV-1 Nef increases T cell activation in a stimulus-dependent manner. Proc. Natl. Acad. Sci. U.S.A. 96, 8167-8172. doi: 10.1073/PNAS.96.14.8167.
85. Sen, R., and Baltimore, D. (1986). Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46, 705-716. doi: 10.1016/0092-8674(86)90346-6.
86. Simmons, A., Aluvihare, V., and McMichael, A. (2001). Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. Immunity 14, 763-777. doi: 10.1016/S1074-7613(01)00158-3.
87. Skaug, B., Jiang, X., and Chen, Z. J. (2009). The role of ubiquitin in NF-κB regulatory pathways. Annu. Rev. Biochem. 78, 769-796. doi: 10.1146/annurev.biochem.78.070907.102750.
88. Sloan, R. D., Wainberg, M. A., Bar-Magen, T., Sloan, R., Faltenbacher, V., Donahue, D., et al. (2011). The role of unintegrated DNA in HIV infection. Retrovirology 8:52. doi: 10.1186/1742-4690-8-52.
89. Sodora, D. L., Allan, J. S., Apetrei, C., Brenchley, J. M., Douek, D. C., Else, J. G., et al. (2009). Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat. Med. 15, 861-865. doi: 10.1038/nm.2013.
90. Sugden, S. M., Bego, M. G., Pham, T. N. Q., and Cohen, é. A. (2016). Remodeling of the host cell plasma membrane by HIV-1 Nef and Vpu: a strategy to ensure viral fitness and persistence. Viruses 8:67. doi: 10.3390/v8030067.
91. Swigut, T., Shohdy, N., and Skowronski, J. (2001). Mechanism for down-regulation of CD28 by Nef. EMBO J. 20, 1593-1604. doi: 10.1093/emboj/20.7.1593.
92. Takeuchi, J. S., Ren, F., Yoshikawa, R., Yamada, E., Nakano, Y., Kobayashi, T., et al. (2015). Coevolutionary dynamics between tribe Cercopithecini tetherins and their lentiviruses. Sci. Rep. 5:16021. doi: 10.1038/srep16021.
93. Tokarev, A., Suarez, M., Kwan, W., Fitzpatrick, K., Singh, R., and Guatelli, J. (2013). Stimulation of NF-κB activity by the HIV restriction factor BST2. J. Virol. 87, 2046-2057. doi: 10.1128/JVI.02272-12.
94. Tong-Starksen, S. E., Luciw, P. A., and Peterlin, B. M. (1987). Human immunodeficiency virus long terminal repeat responds to T-cell activation signals. Proc. Natl. Acad. Sci. U.S.A. 84, 6845-6849. doi: 10.1073/pnas.84.19.6845.
95. Utay, N. S., and Douek, D. C. (2016). Interferons and HIV infection: the good, the bad, and the Ugly. Pathog. Immun. 1, 107-116. doi: 10.20411/pai.v1i1.125.
96. Vallabhapurapu, S., and Karin, M. (2009). Regulation and function of NF-κB transcription factors in the immune system. Annu. Rev. Immunol. 27, 693-733. doi: 10.1146/annurev.immunol.021908.132641.
97. Varin, A., Decrion, A.-Z., Sabbah, E., Quivy, V., Sire, J., Van Lint, C., et al. (2005). Synthetic Vpr protein activates activator protein-1, c-Jun N-terminal kinase, and NF-κB and stimulates HIV-1 transcription in promonocytic cells and primary macrophages. J. Biol. Chem. 280, 42557-42567. doi: 10.1074/jbc.M502211200.
98. Wang, D., and Baldwin, A. S. J. (1998). Activation of nuclear factor-κB-dependent transcription by tumor necrosis factor-a is mediated through phosphorylation of RelA/p65 on serine 529. J. Biol. Chem. 273, 29411-29416. doi: 10.1074/jbc.273.45.29411.
99. Williams, S. A., Chen, L.-F., Kwon, H., Fenard, D., Bisgrove, D., Verdin, E., et al. (2004). Prostratin antagonizes HIV latency by activating NF-κB. J. Biol. Chem. 279, 42008-42017. doi: 10.1074/jbc.M402124200.
100. Williams, S. A., Chen, L.-F., Kwon, H., Ruiz-Jarabo, C. M., Verdin, E., and Greene, W. C. (2006). NF-κB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J. 25, 139-149. doi: 10.1038/sj.emboj.7600900.
101. Williams, S. A., Kwon, H., Chen, L.-F., and Greene, W. C. (2007). Sustained induction of NF-κB is required for efficient expression of latent human immunodeficiency virus type 1. J. Virol. 81, 6043-6056. doi: 10.1128/JVI.02074-06.
102. Witte, V., Laffert, B., Gintschel, P., Krautkrämer, E., Blume, K., Fackler, O. T., et al. (2008). Induction of HIV transcription by Nef involves Lck activation and protein kinase C theta raft recruitment leading to activation of ERK1/2 but not NF kappa B. J. Immunol. 181, 8425-8432. doi: 10.4049/jimmunol.181.12.8425.
103. Xu, X. N., Laffert, B., Screaton, G. R., Kraft, M., Wolf, D., Kolanus, W., et al. (1999). Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor ζ chain. J. Exp. Med. 189, 1489-1496. doi: 10.1084/jem.189.9.1489.
104. Yoon, K., and Kim, S. (1999). Lack of negative influence on the cellular transcription factors NF-κB and AP-1 by the nef protein of human immunodeficiency virus type 1. J. Gen. Virol. 80, 2951-2956. doi: 10.1099/0022-1317-80-11-2951.
105. Yu, H., Khalid, M., Heigele, A., Schmökel, J., Usmani, S. M., van der Merwe, J., et al. (2015). Lentiviral Nef proteins manipulate T cells in a subset-specific manner. J. Virol. 89, 1986-2001. doi: 10.1128/JVI.03104-14.
106. Zhang, F., Wilson, S. J., Landford, W. C., Virgen, B., Gregory, D., Johnson, M. C., et al. (2009). Nef Proteins from simian immunodeficiency viruses are tetherin antagonists. Cell Host Microbe 6, 54-67. doi: 10.1016/j.chom.2009.05.008.
107. Zhang, L., Huang, Y., Yuan, H., Chen, B. K., Ip, J., and Ho, D. D. (1997). Identification of a replication-competent pathogenic human immunodeficiency virus type 1 with a duplication in the TCF-1α region but lacking NF-κB binding sites. J. Virol. 71, 1651-1656.
108. Zhong, H., May, M. J., Jimi, E., and Ghosh, S. (2002). The phosphorylation status of nuclear NF-κB determines its association with CBP/p300 or HDAC-1. Mol. Cell 9, 625-636. doi: 10.1016/S1097-2765(02)00477-X.